Gellan-Based Composite System for the Treatment of Nervous Tissue Injuries

Published in Pharmaceutics, vol. 13(2), 164 (2021) · MDPI · Open access, CC BY
DOI: 10.3390/pharmaceutics13020164

Summary

Injuries to the nervous system affect more than a billion people and weigh heavily on quality of life, yet delivering a neuroprotective drug precisely where the damage is remains difficult. This study designs a gellan gum-based composite for local delivery of RC-33, an agonist of the sigma-1 receptor with neuroprotective activity. The system combines cross-linked electrospun nanofibres with a second component, so that the fibres provide structure and residence at the injury site while the drug is released locally instead of systemically.

Authors & Affiliations

  • Barbara Vigani
    Department of Drug Sciences, University of Pavia, Italy
  • Caterina Valentino
    Department of Drug Sciences, University of Pavia, Italy
  • Valeria Cavalloro
    Department of Drug Sciences, University of Pavia, Italy
  • Laura Catenacci
    Department of Drug Sciences, University of Pavia, Italy
  • Milena Sorrenti
    Department of Drug Sciences, University of Pavia, Italy
  • Giuseppina Sandri
    Department of Drug Sciences, University of Pavia, Italy
  • Maria Cristina Bonferoni
    Department of Drug Sciences, University of Pavia, Italy
  • Chiara Bozzi
    Department of Drug Sciences, University of Pavia, Italy

Linari Electrospinning Systems

Electrospinning Starter Kit STKIT-40
The nanofibres were produced on a Linari Engineering system (Grosseto, Italy) with a Linari high voltage power supply and a syringe pump - the complete station described on our Starter Kit page, control unit HVG-CONT-LCD.

Topics

Nervous Tissue Injuries Local Drug Delivery Neuroprotection Composite Systems

Materials

Gellan gum RC-33 (sigma-1 agonist)
Read the full publication
Back to blog